Contras: Contiene conservantes y colorantes artificiales
Jpn Pharmacol Ther 2018;46:561580.
Thats according to new research from the University of British Columbia showing that medications known as GLP-1 agonistswhich includes brands like Wegovy, Ozempic, Rybelsus and Saxendaare associated with an increased risk of serious medical conditions including stomach paralysis, pancreatitis and bowel obstruction
Some patients respond better to compounded tirzepatide or the GLP-Squared dual-compound protocol, which target additional receptor pathways (GIP in particular)
Other anecdotes claimed they gained weight back almost immediately, sometimes gaining more weight or even double the weight, then they previously had
Both companies are also expanding beyond obesity into adjacent conditions, which could reinforce the long-term investment case